Background Chemotherapy-induced peripheral neuropathy (CIPN) is a problematic adverse
event for breast cancer patients receiving taxane antimitotic agents. We evaluated the …

Taxanes are key drugs for patients with breast cancer. A major adverse effect associated
with the administration of the taxane docetaxel is chemotherapy-induced peripheral …

Background Chemotherapy-induced peripheral neuropathy (CIPN) frequently occurs in
treatment with taxanes. However, no effective management has been established. We …

Chemotherapy induced peripheral neuropathy (CIPN) is an adverse effect of taxane-based
chemotherapy, the most frequently used therapy for treating breast cancer. CIPN is a serious …

Purpose Taxanes are a cornerstone treatment in early and advanced stage breast cancer
and in other common solid tumor malignancies; however, the development of chemotherapy …

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse
effect of taxane treatment and can significantly affect patient quality of life. Currently, there …

e20574 Background: CIPN is a common and potentially dose-limiting complication of many
effective cytotoxic agents. Taxanes are the cornerstone of treatment in BC. Limited data are …

Taxanes are key drugs for patients with breast cancer. A major adverse effect of taxanes is
peripheral neuropathy (PN). To investigate the ability of compression therapy using sleeves …

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity
of several commonly used chemotherapy drugs including taxanes, vinca alkaloids, and …

Background Though the incidence, characteristics, and pathogenesis of chemotherapy
induced peripheral neuropathy (CIPN) by taxane based chemotherapy were extensively …